← Back to headlines
Novartis Reports New Cosentyx Data in Polymyalgia Rheumatica
Novartis (NVS) has announced new data regarding its drug Cosentyx® in the treatment of Polymyalgia Rheumatica.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
